The InXite mobile app (downloadable from the App Store or on Google Play under InXite Data Platform) will help you understand your risk of contracting the coronavirus and many other illnesses and diseases.

Download on the Apple StoreGet it on Google Play

It starts with a simple health risk assessment and health history along with current health issues and medications. Keep a daily record of your health by tracking it on your app and notify your provider if you begin experiencing symptoms. You can even share your health information with the providers you choose with a unique QR code! If you don’t have a healthcare provider, you can find a highly-rated provider right from the app along with recommended resources near you, including telehealth options. Get started on taking control of your health—right from the convenience of your smartphone. InXite is committed to updating you with all the latest coronavirus news as it happens. Stay tuned for further developments.


InXite Takes Covid-19 Very Seriously

Coronavirus—what you need to know

The coronavirus (COVID-19) pandemic is causing increasing concern worldwide. InXite Health Systems is carefully monitoring this situation to provide our clients, patients and employees with the most up-to-date information as it becomes available. Leading researchers from the Centers for Disease Control and Prevention (CDC) provide the most current information on this disease, including announcements from the White House.

Here are some precautions to take:

• Stay home when you are sick (espe­cial­ly if you are expe­ri­enc­ing res­pi­ra­to­ry symp­toms such as fever, cough, short­ness of breath, sore throat, run­ny or stuffy nose, body aches, headaches, chills or fatigue).
• Wash your hands fre­quent­ly with warm, soapy water for at least 20 sec­onds.
• Cov­er your mouth with tis­sues when­ev­er you sneeze, and dis­card used tis­sues in the trash.
• Avoid peo­ple who are sick with res­pi­ra­to­ry symp­toms.
• Clean fre­quent­ly touched sur­faces.

Here are the President’s coronavirus guidelines for America:


• Lis­ten to and fol­low the direc­tions of your STATE AND LOCAL AUTHORITIES
IF YOU FEEL SICK, stay home. Do not go to work. Con­tact your med­ical provider.
IF YOUR CHILDREN ARE SICK, keep them at home. Do not send them to school. Con­tact your med­ical provider.
the entire house­hold at home. Do not go to work. Do not go to school. Con­tact your med­ical provider.
IF YOU ARE AN OLDER PERSON, stay home and away from oth­er peo­ple.
IF YOU ARE A PERSON WITH A SERIOUS UNDERLYING HEALTH CONDITION that can put you at increased risk (for exam­ple, a con­di­tion that impairs your lung or heart func­tion or weak­ens your immune sys­tem), stay home and away from oth­er peo­ple.


Even if you are young, or otherwise healthy, you are at risk and your activities can increase the risk for others. It is critical that you do your part to slow the spread of the coronavirus.

• Work or engage in school­ing from home when­ev­er pos­si­ble.
IF YOU WORK IN A CRITICAL INFRASTRUCTURE INDUSTRY, as defined by the Depart­ment of Home­land Secu­ri­ty, such as health­care ser­vices and phar­ma­ceu­ti­cal and food sup­ply, you have a spe­cial respon­si­bil­i­ty to main­tain your nor­mal work sched­ule. You and your employ­ees should fol­low CDC guid­ance to pro­tect your health a work.• AVOID SOCIAL GATHERINGS in groups of more than 10 peo­ple.
• Avoid eat­ing or drink­ing at bars, restau­rants and food courts—USE DRIVE-THRU, PICKUP OR DELIVERY OPTIONS.
AVOID DISCRETIONARY TRAVEL, shop­ping trips and social vis­its.
DO NOT VISIT nurs­ing homes or retire­ment or long-term care facil­i­ties unless to pro­vide crit­i­cal assis­tance.

o Wash your hands, espe­cial­ly after touch­ing any fre­quent­ly used item or sur­face.
o Avoid touch­ing your face.
o Sneeze or cough into a tis­sue or the inside of your elbow.
o Dis­in­fect fre­quent­ly used items and sur­faces as much as pos­si­ble.

Pres­i­dent Trump expands tele­health ben­e­fits for Medicare ben­e­fi­cia­ries dur­ing COVID-19 out­break

The Trump Admin­is­tra­tion today announced expand­ed Medicare tele­health cov­er­age that will enable ben­e­fi­cia­ries to receive a wider range of health­care ser­vices from their doc­tors with­out hav­ing to trav­el to a health­care facil­i­ty. Begin­ning on March 6, 2020, Medicare—administered by the Cen­ters for Medicare & Med­ic­aid Ser­vices (CMS)—will tem­porar­i­ly pay clin­i­cians to pro­vide tele­health ser­vices for ben­e­fi­cia­ries resid­ing across the entire coun­try. Read the arti­cle in its entire­ty here.

Text mes­sage rumors of a nation­al quar­an­tine are FAKE

There is no nation­al lock­down. The CDC has and will con­tin­ue to post the lat­est guid­ance on

The CDC rec­om­men­da­tions for clean­ing and dis­in­fect­ing your home

Clean­ing of vis­i­bly dirty sur­faces fol­lowed by dis­in­fec­tion is a best prac­tice mea­sure for pre­ven­tion of COVID-19 and oth­er viral res­pi­ra­to­ry ill­ness­es in house­holds and com­mu­ni­ty set­tings. Click here for detailed clean­ing and dis­in­fect­ing prac­tices.

RSS Breaking News 2

RSS Breaking News 3

  • COVAX Announces new agree­ment, plans for first deliv­er­ies Jan­u­ary 22, 2021
    COVAX announced the sign­ing of an advance pur­chase agree­ment for up to 40 mil­lion dos­es of the Pfiz­er-BioN­Tech vac­cine; roll­out to com­mence with suc­cess­ful exe­cu­tion of sup­ply agreements.Additionally, COVAX announced that, pend­ing WHO emer­gency use list­ings, near­ly 150 mil­lion dos­es of the AstraZeneca/Oxford can­di­date are antic­i­pat­ed to be avail­able in Q1 2021, via exist­ing agree­ments […]
  • GACVS COVID-19 Vac­cine Safe­ty sub­com­mit­tee meet­ing to review reports of deaths of very frail elder­ly indi­vid­u­als vac­ci­nat­ed with Pfiz­er BioN­Tech COVID-19 vac­cine, BNT162b2 Jan­u­ary 22, 2021
    The GACVS COVID-19 Vac­cine Safe­ty sub­com­mit­tee met vir­tu­al­ly on Tues­day, 19 Jan­u­ary 2021, to review avail­able infor­ma­tion and data on deaths report­ed in frail, elder­ly indi­vid­u­als who had received the Pfiz­er BioN­Tech COVID-19 mRNA vac­cine, BNT162b2 (here­after, BNT162b2). Experts invit­ed from the Euro­pean Med­i­cines Agency (EMA) and the Upp­sala Mon­i­tor­ing Cen­ter (UMC) pro­vid­ed an overview […]
  • WHO Infor­ma­tion Notice for IVD Users 2021/01 Jan­u­ary 19, 2021
    Prod­uct type: All in vit­ro diag­nos­tic med­ical devices (IVDs) for detec­tion of SARS-CoV­‑2 Date: 18 Jan­u­ary 2021                                                                    WHO-iden­ti­fi­er: 2021/01, ver­sion 1   Tar­get audi­ence: Lab­o­ra­to­ry pro­fes­sion­als and users of IVDs.  Pur­pose of this notice: To request that IVD users mon­i­tor muta­tions of SARS-CoV­‑2 and their impact on diag­no­sis. Descrip­tion of the prob­lem: Fol­low­ing the detec­tion of SARS-CoV­‑2 vari­ants con­tain­ing muta­tions, includ­ing SARS-CoV­‑2 VOC 202012/01, and SARS-CoV­‑2 501Y.V2, WHO reminds users of IVDs to mon­i­tor detec­tion rates for SARS-CoV­‑2 at their site.  IVD users should rou­tine­ly review test results to detect unex­pect­ed increas­es or […]
  • State­ment to the 148th Exec­u­tive Board by the Chair of the Review Com­mit­tee on the Func­tion­ing of the Inter­na­tion­al Health Reg­u­la­tions (2005) dur­ing the COVID-19 Response Jan­u­ary 19, 2021
    Hon­or­able Chair, Excel­len­cies, Direc­tor-Gen­er­al, Ladies and Gen­tle­men Thank you once again for the oppor­tu­ni­ty to pro­vide you with an update on the work of the Review Com­mit­tee on the Func­tion­ing of the Inter­na­tion­al Health Reg­u­la­tions (2005) dur­ing COVID-19. As you know, this Com­mit­tee was con­vened by the Direc­tor-Gen­er­al on 8 Sep­tem­ber 2020, in line with […]
  • WHO Guide­lines for estab­lish­ing a poi­son cen­tre Jan­u­ary 18, 2021
    The Guide­lines for estab­lish­ing a poi­son cen­tre pro­vides infor­ma­tion on the ser­vices that may be offered by a poi­son cen­tre as well as detailed prac­ti­cal guid­ance on plan­ning and oper­a­tions.
  • Sci­en­tists tack­le vac­cine safe­ty, effi­ca­cy and access at glob­al R&D forum Jan­u­ary 16, 2021
    More than 2,800 sci­en­tists from 130 coun­tries gath­ered on Fri­day (Jan­u­ary 15) in a vir­tu­al forum host­ed by the World Health Orga­ni­za­tion (WHO) to iden­ti­fy knowl­edge gaps and set research pri­or­i­ties for vac­cines against SARS-CoV­‑2, the virus that caus­es COVID-19.They dis­cussed the safe­ty and effi­ca­cy of exist­ing vac­cines and new can­di­dates, ways to opti­mize lim­it­ed […]
  • State­ment on the sixth meet­ing of the Inter­na­tion­al Health Reg­u­la­tions (2005) Emer­gency Com­mit­tee regard­ing the coro­n­avirus dis­ease (COVID-19) pan­dem­ic Jan­u­ary 15, 2021
    The sixth meet­ing of the Emer­gency Com­mit­tee con­vened by the WHO Direc­tor-Gen­er­al under the Inter­na­tion­al Health Reg­u­la­tions (2005) (IHR) regard­ing the coro­n­avirus dis­ease (COVID-19) took place on Thurs­day, 14 Jan­u­ary 2021 from 12:15 to 16:45 Gene­va time (CEST). Pro­ceed­ings of the meet­ing­Mem­bers and Advi­sors of the Emer­gency Com­mit­tee were con­vened by video­con­fer­ence. The Direc­tor-Gen­er­al wel­comed the Com­mit­tee, expressed the need for glob­al […]
  • Emer­gency Com­mit­tee on COVID-19 advis­es on vari­ants, vac­cines Jan­u­ary 15, 2021
    The COVID-19 pan­dem­ic con­tin­ues to con­sti­tute a Pub­lic Health Emer­gency of Inter­na­tion­al Con­cern (PHEIC), accord­ing to the WHO Emer­gency Com­mit­tee (EC) on COVID-19.The EC met vir­tu­al­ly yes­ter­day (14 Jan­u­ary) at the request of WHO Direc­tor-Gen­er­al Dr Tedros Adhanom Ghe­breye­sus to review the emerg­ing vari­ants of SARS-CoV­‑2, the virus that caus­es COVID-19, and to con­sid­er the […]
  • World Health Assem­bly endors­es the 1st ever res­o­lu­tion on menin­gi­tis pre­ven­tion and con­trol Jan­u­ary 14, 2021
    At the 73rd Ses­sion of the World Health Assem­bly, Mem­ber States over­whelm­ing­ly endorsed a res­o­lu­tion call­ing for urgent action on menin­gi­tis pre­ven­tion and con­trol through the imple­men­ta­tion of a bold, com­pre­hen­sive glob­al roadmap to defeat menin­gi­tis by 2030. Devel­oped under WHO lead­er­ship, through exten­sive and broad con­sul­ta­tion, this glob­al roadmap paves the way for the […]
  • WHO devel­oped a glob­al lab­o­ra­to­ry pro­to­col for mea­sur­ing trans fat in foods Jan­u­ary 13, 2021
    WHO’s new lab­o­ra­to­ry pro­to­col enti­tled “Glob­al pro­to­col for mea­sur­ing fat­ty acid pro­files of foods with empha­sis on mon­i­tor­ing trans fats orig­i­nat­ed from par­tial­ly hydro­genat­ed oils” pro­vides a glob­al­ly har­mo­nized method to mea­sure trans fats in foods. It will enable coun­tries to assess the lev­els of trans-fat­ty acids (TFA) in their food sup­ply to under­stand key […]